Atrinsic (PTIX) Projected to Announce Quarterly Earnings on Tuesday

Atrinsic (NASDAQ:PTIX) is anticipated to announce its resultson Tuesday, August 18th. Analysts expect Atrinsic to post earnings of ($4.48) per share for the quarter.

Atrinsic Stock Performance

Shares of NASDAQ PTIX opened at $0.35 on Tuesday. The company’s 50 day moving average price is $0.33 and its 200-day moving average price is $0.48. Atrinsic has a 52-week low of $0.13 and a 52-week high of $6.20. The company has a market capitalization of $633,500.00, a P/E ratio of -0.04 and a beta of 1.07.

About Atrinsic

Protagenic Therapeutics, Inc, a biopharmaceutical company, engages in the discovery and development of therapeutics to treat stress-related neuropsychiatric and mood disorders. Its lead compound comprises PT00114, a synthetic form of teneurin carboxy-terminal associated peptide, an endogenous brain signaling peptide that can dampen overactive stress responses. Protagenic Therapeutics, Inc is headquartered in New York, New York.